Aaron Schwartz

Director of R&D Innovation Sourcing

Novo Nordisk

Aaron is a Director in Novo Nordisk’s R&D Innovation Sourcing team. In this capacity, Aaron is responsible for the search an evaluation of new therapeutics and enabling technologies for protein, peptide, and antibody drugs. Prior to joining Novo Nordisk, Aaron worked in the MIT Technology Licensing Office for 13½ years. During this time, he worked on license and sponsored research agreements with life sciences companies from startups to big biotech/pharma and everything in between. He also managed a portfolio of over 650 technologies. Before Aaron’s time at MIT, he was a management consultant to big pharma and a startup. Aaron has an undergrad degree in biology from the University of Chicago and a Masters degree in biology from MIT.